Recent Articles

• 
  Biotech

  Korean Tech in KRW 40 Trillion Drug Market

  Journalists from the Dong-A Ilbo IT Science Team introduce noteworthy technologies, trends, and companies in the fields of IT, science, space, and bio. "What is this company?" The behind-the-scenes stories of tech companies changing the world with technology! From ideas that surprised the world to t

  2025.09.30
• 
  Medical / Drug Development

  Ildong Confirms Obesity Drug's Efficacy: 13.8% Loss

  View of the headquarters of Ildong Pharmaceutical Group Ildong Pharmaceutical Group held an investor relations (IR) meeting on the 29th and disclosed the topline data from Phase 1 clinical trials related to the obesity and diabetes treatment candidate 'ID110521156'. The new drug candidate ID11052115

  2025.09.29
• 
  Medical / Research

  Korean Scientist Finds Why AI Spreads, Kills

  The reason the H5N1 virus, prevalent in North America, spreads throughout the body and invades the nervous system has been identified as two mutations. Getty Images Korea The reason the H5N1 avian influenza virus, prevalent in North America, is highly contagious and deadly has been identified. A dom

  2025.09.29
• 
  MedTech

  Brainwave Technology Advances from Training to Diagnosis

  Park Byung-woon, CEO of Panaxtos As artificial intelligence (AI) and digital healthcare present new paradigms in the medical field, the mental health management sector utilizing brainwave technology is gaining attention as a next-generation growth engine. With the advent of a super-aged society, the

  2025.09.29
• 
  MedTech

  ReadyCure CEO: Digital X-ray Helaxon Revolutionizes Brain Disease Treatment

  People fear 'degenerative brain diseases' such as Alzheimer's and Parkinson's disease because they drastically reduce the quality of life and cause suffering not only to the patients but also to their families and those around them. The main causes of degenerative brain diseases include aging, alcoh

  2025.09.26
• 
  Medical / Digital Healthcare

  Neumafit Wins KRW 15.1 Billion ARPA-H Project

  Neumafit has been finally selected for the '2025 Second Korean ARPA-H Project' promoted by the K-Health Future Initiative under the Korea Health Industry Development Institute, affiliated with the Ministry of Health and Welfare. The project is led by Korea University College of Medicine, with Neumaf

  2025.09.26
• 
  Bio / Health Supplements

  Dong-A Pharm Launches CU Exclusive Health Brand

  CU exclusive health functional food brand ‘Selparex Baro’. Provided by Dong-A Pharmaceutical Dong-A Pharmaceutical announced on the 26th that it has launched the CU exclusive health functional food brand ‘Selparex Baro’, which allows consumers to conveniently manage their health at convenience store

  2025.09.25
• 
  Medical / Drug Development

  Proprietary Dual Antibody Drug Emerges as Game Changer

  CEO Seung-Yong Sung of Shaperon Co., Ltd. (pictured) received the '2025 Korea Management Award' in the CEO-Research and Development category. This marks the fourth consecutive year. Shaperon's 'Multi Nanomab' is a tenth the size of existing antibodies and is manufactured in a single-chain form, inno

  2025.09.25
• 
  Medical / Clinical Case

  Minimally Invasive Thyroid Cancer Surgery Speeds Recovery

  Ha Jung-hoon, Director of ENT, Thank You Seoul ClinicWhen it comes to thyroid cancer surgery, one often imagines a long incision in the center of the neck. This leads to fears about the surgery and concerns about scarring. However, recently, 'minimally invasive thyroid cancer surgery,' which maintai

  2025.09.24
• 
  Biotech

  Farmfirm Selected for Bio Sector in Startup Program

  FarmFirm has been selected for the bio sector of the '2025 Super Gap Startup 1000+ Project (Micro DIPS)' organized by the Ministry of SMEs and Startups. Provided by FarmFirmThe AI and big data-based healthcare platform FarmFirm announced on the 24th that it has been selected for the bio sector of th

  2025.09.24